Abstract
We show that people with a silent glioma have more chances to die from their gliomas than from another unrelated cause. This result, combined with the knowledge that diffuse low-grade gliomas remain clinically silent for a very long period (>10 years), grounds the screening and preventive treatment of silent diffuse low-grade glioma. © 2014 American Cancer Society.
Cite
CITATION STYLE
APA
Mandonnet, E., De Witt Hamer, P., Pallud, J., Bauchet, L., Whittle, I., & Duffau, H. (2014, June 15). Silent diffuse low-grade glioma: Toward screening and preventive treatment? Cancer. John Wiley and Sons Inc. https://doi.org/10.1002/cncr.28610
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free